DePeaux, Kristin http://orcid.org/0000-0001-8460-727X
Delgoffe, Greg M. http://orcid.org/0000-0002-2957-8135
Article History
Accepted: 16 March 2021
First Online: 29 April 2021
Competing interests
: G.M.D. declares competing financial interests and has submitted patents covering the use of PGC1α in cell therapies, metabolic manipulation of culture conditions for cell therapies, and the use of leptin and other adipokines in oncolytic viruses that are licensed or pending and is entitled to a share in net income generated from the licencing of these patent rights for commercial development. G.M.D. consults for and/or is on the scientific advisory boards of BlueSphere Bio, Century Therapeutics, Novasenta, Pieris Pharmaceuticals and Kalivir, has grants from bluebird bio, Novasenta, Pfizer, Pieris Pharmaceuticals, TCR2 and Western Oncolytics/Kalivir, and owns stock in Novasenta and BlueSphere Bio. K.D. declares no competing interests.